Black Lung Disease Industry Forecast to Hit $19.23 Billion by 2029 With a Strong 15.2% CAGR

Global Black Lung Disease Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Current (2025) And Forecast (2029) Sizes Of The Black Lung Disease Market?

The black lung disease market has seen substantial expansion in recent years. It is forecast to increase from $9.66 billion in 2024 to $10.92 billion by 2025, progressing at a compound annual growth rate (CAGR) of 13.1%. This growth witnessed in past periods is attributable to the development of the coal mining industry, enhanced awareness and education, the availability of compensation and benefits, and various legislative and legal advancements.

The black lung disease market size is anticipated to experience swift expansion in the coming years, with projections indicating it will reach $19.23 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.2%. This projected growth during the forecast period is attributed to factors such as public health initiatives, significant medical advancements, a wider array of treatment options, and the impactful contributions of advocacy and support organizations. Major trends anticipated in this period include advanced diagnostic techniques, ongoing research and prevention efforts, improved healthcare access, and continuous technological progress.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

What Are The Main Drivers Boosting The Black Lung Disease Industry’s Expansion?

The expanding scope of mining activities is projected to fuel the growth of the black lung disease market moving forward. These mining operations entail extracting valuable minerals, ores, and other geological materials from the earth’s crust. Black lung disease is a condition resulting from mining activities and breathing in coal mine dust, which contains dangerous carbon-containing particles and impacts coal miners. For instance, in July 2023, data from the International Energy Agency (IEA), a France-based intergovernmental organization, indicated that critical mineral production experienced a significant surge, increasing by 30% to reach $41 billion in 2022, building on a 20% gain in 2021. Over the past five years, the demand for critical minerals has notably escalated, showing a threefold increase in lithium consumption and a 70% rise in cobalt demand. Therefore, increasing mining activities are driving the growth of the black lung disease market.

What Are The Major Segment Types Covered In The Black Lung Disease Market?

The black lung diseasemarket covered in this report is segmented –

1) By Type: Simple Coal Worker’s Pneumoconiosis; Complicated Coal Worker’s Pneumoconiosis; Other Types

2) By Treatment: Oxygen Therapy; Bronchodilators; Lung Transplant; Stem Cell Therapy; Other Treatment

3) By Diagnosis: Biopsy; Imaging; Full Blood Count; Pulmonary Or Lung Function Tests; Physical Examination; Other Diagnosis

4) By End Users: Hospitals And Clinics; Research Organizations And Academic Institutes; Diagnostic Centers And Labs; Other End Users

Subsegments:

1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis; Symptomatic Simple Pneumoconiosis

2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF); Complicated Pneumoconiosis With Respiratory Symptoms

3) By Other Type: Mixed Dust Pneumoconiosis; Other Related Respiratory Diseases

Which Leading Companies Dominate The Black Lung Disease Market Share?

Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Black Lung Disease Market?

North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Black Lung Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12988&type=smp

Browse Through More Reports Similar to the Global Black Lung Disease Market 2025, By The Business Research Company

Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

Respiratory Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report

Respiratory Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model